Point72 Asset Management, L.P.
Position in MIRM — Mirum Pharmaceuticals, Inc.
CIK 1603466
STAMFORD, CT
Position in MIRM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$32,055,028
+$16,996,533 QoQ
Shares Held
346,991
+82.0% QoQ
Ownership
0.569%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
14 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MIRM Over Time
Shares Held
Position Value (USD)
Derivatives in MIRM
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$609,708
PutShares
6,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $2,393,450,612 across 188 Biotechnology names. MIRM ranks #22 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,183,918 | $168,319,021 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
225,510 | $118,047,719 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
3,229,939 | $102,453,665 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
846,801 | $73,646,282 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
424,750 | $71,791,245 | |
| 6 | ABVX |
Abivax S.A.
|
637,736 | $71,011,903 | |
| 7 | LEGN |
Legend Biotech Corp
|
3,886,017 | $70,298,047 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
358,634 | $67,799,757 |
All Filings in MIRM
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $609,708 | 6,600 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $32,055,028 | 346,991 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $647,718 | 8,200 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $15,058,495 | 190,638 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $647,718 | 8,200 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $57,964,384 | 790,675 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $13,173,690 | 258,866 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,456,014 | 232,098 | Shares | Defined | 2025-07-21 | |
| 2023-06-30 | $15,548,853 | 601,038 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,389,660 | 557,438 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,620,445 | 339,510 | Shares | Defined | 2023-05-15 | |
| 2022-03-31 | $3,377,625 | 153,389 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,021,745 | 314,843 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,876,448 | 144,400 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $325,052 | 18,800 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $99,100 | 5,000 | Shares | Defined | 2021-05-17 | |
| 2020-06-30 | $1,895,695 | 97,415 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||